Kunming Pharmaceutical Commercial and Lunan Pharmaceutical Announce Strategic Partnership, Pioneering New Models in Pharma Collaboration

　　【Pharmaceutical Network Corporate News】 Recently, Kunming Pharma.Corp.Medicine Business Co.,Ltd and Lunan Pharmaceutical Group Corporation formally signed an in-depth strategic cooperation agreement. Both parties will integrate their respective advantageous resources to explore multi-field and multi-dimensional cooperation models.
 

Two Major Pharmaceutical Companies Reach Strategic Cooperation (Image Source: Pharmaceutical Network)
 

With the in-depth implementation of the "Healthy China" strategy and the advancement of medical and health system reforms to a deeper level, the pharmaceuticals distribution industry has entered a new era of historic change. In response to the policies and trends within the pharmaceuticals industry, it is crucial to further strengthen friendly cooperation and complementary advantages between upstream and downstream enterprises. The collaboration between Kunming Pharma.Corp.Medicine Business Co., Ltd. and Lunan Pharmaceutical will further achieve mutual benefit and support.
 

It is reported that Lunan Pharmaceutical is a comprehensive pharmaceutical group that integrates the production, research, and sales of traditional Chinese medicine, chemical drugs, and biologics. In recent years, Lunan Pharmaceutical Group has adhered to innovation-driven development and a globalization strategy. Starting from aligning with international standards, the company has continuously increased investment in R&D and innovation, focusing on promoting high standards and internationalization in R&D. For instance, the company established an International Drug Research and Development Center in 2017, which has completed the R&D registration of 44 formulations in 80 countries.
 

Kunming Pharma.Corp.Medicine Business Co., Ltd. has always explored the value path in the pharmaceutical distribution field with its core values of "openness, innovation, professionalism, and efficiency," and is committed to building a regional pharmaceutical distribution ecosystem platform with innovative value. It aims to become a comprehensive pharmaceutical service platform in Yunnan Province with grassroots advantages, direct sales capabilities, and network value. The company solidifies the grassroots market, deepens its pharmaceutical distribution business, continuously improves its business structure, and focuses on leveraging its grassroots network advantages. It actively promotes internal strategic procurement, introduces nationally produced varieties, strengthens basic management, and drives the coordinated development of subsidiaries. Kunming Pharma enhances logistics service efficiency through multi-warehouse networking, creating an integrated, standardized, and intensive modern pharmaceutical logistics system, and builds an efficient, agile, and intelligent modern supply chain service channel.
 

The signing of this strategic cooperation agreement marks a new starting point for symbiosis and win-win outcomes between Kunming Pharma.Corp.Medicine Business Co., Ltd. and Lunan Pharmaceutical. This represents not only a significant milestone in the development of both companies but also a new attempt and opportunity in the pharmaceutical cooperation model.
 

Among them, Lunan Pharmaceutical pointed out that Lunan Pharmaceutical Group Corporation is a large-scale comprehensive pharmaceutical group in China. The company holds a high position in product quality, independent innovation capability, and management level; Kunming Pharma.Corp.Medicine Business Co., Ltd has a strong marketing network and market innovation capability in Yunnan Province. Through this strategic cooperation, the two companies will achieve mutual benefit, strong alliance, and win-win cooperation.
 

KPC Group stated that both parties have reached this strategic cooperation consensus with the goal of complementary advantages and win-win development. KPC Medicine Business will firmly consolidate basic management, accelerate the three-year strategic goal of pure sales transformation, uphold the value of being chosen by upstream industrial enterprises, share resources with Lunan Pharmaceutical, and achieve a new leap in cooperation.
 

Kunming Pharmaceutical Group also stated that Kunming Pharma.Corp.Medicine Business Co.,Ltd will spare no effort to leverage its grassroots advantages, cooperate with Lunan Pharmaceutical to fully promote strategic varieties, solidify the foundation of the existing market, and assist Lunan Pharmaceutical in establishing more efficient commercial channels. Kunming Pharma.Corp.Medicine Business Co.,Ltd will also rely on this cooperation to achieve business empowerment and strategic upgrading.
 

Disclaimer: In no event shall the information or opinions expressed in this article constitute investment advice to any person.